BioCentury
ARTICLE | Company News

Trimeris off after Arigene ends offer

December 30, 2009 12:43 AM UTC

Trimeris Inc. (NASDAQ:TRMS) fell $0.53 (17%) to $2.65 on Tuesday after Arigene Co. Ltd. (KOSDAQ:067850) terminated a tender offer to acquire the HIV company for $3.60 per share, or about $82.1 million...